BioTech Nation ... with Dr. Moira Gunn

Hosted by Moira Gunn

ScienceInterviews guests

Website RSS feed

Episodes

190

Latest episode

Oct 2026

Language

About the show

Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.

Listen to episodes

60 recent

October 27, 2026Episode 2604120 min

Redefining Early Intervention for Heart Attacks...Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics

On this episode of BioTech Nation... Dr. Harry Selker & Dr. Atul Deshpande of Immediate Therapeutics speak with Moira about a new treatment that could be administered to heart attack patients right away...potentially before they even arrive at the hospital. Already successfully tested in Phase 2, it’s ready to go into final pivotal trials in Ambulances and Emergency Rooms.

October 20, 2026Episode 2604025 min

AI-Powered Biology...Dr. Shana Kelley, President of Bioengineering & Head of Biohub Chicago

This week on BioTech Nation, what is AI-Powered Biology? Dr. Shana Kelley, President of Bioengineering and Head of Biohub, Chicago for the Chan-Zuckerberg Initiative, discusses how AI can be used to accelerate research, interpret data, and transform how new discoveries are made.

October 13, 2026Episode 2603919 min

Improving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals

This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several million people, but the approval process in the US has had to start back at square one. We look at why that is, and how LB is working on it.

October 6, 2026Episode 2603816 min

From Film to Biotech...Toshi Iida, Chairman, FUJIFILM Biotechnologies

When you think of FUJIFILM, you might be picturing rolls of camera film...but it turns out that's not all they've been working on. FUJIFILM Biotechnologies Chairman Toshi Iida joins to share more about how they're innovating in the world of biotech.

September 29, 2026Episode 2603718 min

Reengineering Chemotherapy for Solid Tumors...Lew Bender, Founder, President & CEO, Intensity Therapeutics

What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.

September 22, 2026Episode 260367 min

A New Path Forward for Cell Therapy...Jeff Liter, Founder & CEO, Luminary Therapeutics

This week on BioTech Nation, Jeff Liter of Luminary Therapeutics shares how his team is taking a new approach to advanced cell therapy, in the hopes of making it more accessible and affordable. Rather than formulating a custom treatment using a patient's own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.

September 15, 2026Episode 2603540 min

Paving the Way for Miracle Drugs...Barry Werth, Author, "The Age of Cures"

On this episode of Biotech Nation...the story of how the United States' pharmaceutical industry came to be, and the people behind it all. Barry Werth joins Moira to discuss his new book, “The Age of Cures: How American Scientists Saved Your Life", about a handful of individuals who revolutionized research and helped build the drug development ecosystem we have today.

September 8, 2026Episode 2603414 min

A Different Approach to Treating Gout...Dr. James Mackay, Co-Founder, CEO, & President, Crystalys Therapeutics

On this episode of BioTech Nation...Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the treatment of gout - a disease that affects more than 13 million people in the United States alone. Dr. Mackay debunks some common misconceptions surrounding the disease, and explains what Crystalys is doing to change the way doctors treat gout going forward.

September 1, 2026Episode 2603320 min

The Potential of Peptide Drugs...Dr. Karsten Eastman, Co-Founder & CEO, Sethera Therapeutics

You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance peptides to make new medicines. Their plan: to develop a drug using enhanced peptides for Triple-Negative Breast Cancer... and they've already received funding.

August 25, 2026Episode 2603213 min

Injectable Ice for Chronic Pain? Sameer Sabir, Co-Founder & CEO, Brixton Biosciences

This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.

Is this your show?

Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.

Claim this listing